Insider Transactions by Kaplan Matthew L.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
NVCTNuvectis Pharma, Inc.Kaplan Matthew L.DirectorMay 12, 2022Buy$16.883,00050,63335,760May 16, 2022, 08:32 AM